NACDS New Products In Brief
This article was originally published in The Tan Sheet
Reckitt doubles down with Mucinex
You may also be interested in...
European sales continue to drag on Reckitt Benckiser even as newly acquired SSL brands contribute heavily to growth, the firm reports July 25.
Reckitt-Benckiser's revenues soared 13 percent in fiscal 2008 as health care and personal product sales grew more than twice as fast as its other segments - a trend the firm expects to continue despite private label competition and the global economic slump
FDA has raised questions on "minor" issues regarding SCOLR Pharma's proposed nonprescription 12-hour pseudoephedrine tablet, according to the firm